Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Walkty

Showing results (91-100 of 108) with videos related to

Pageof 11
Sort By:
Drugs|December 20, 2013
Ceftolozane/tazobactam: a novel cephalosporin/β-lactamase inhibitor combination with activity against multidrug-resistant gram-negative bacilliGeorge G Zhanel, Phillip Chung, Heather Adam, et al.
Journal of Global Antimicrobial Resistance|May 13, 2021
Real-life experience with ceftolozane/tazobactam in Canada: results from the CLEAR (Canadian LEadership on Antimicrobial Real-life usage) registryGeorge G Zhanel, Rita Dhami, Melanie Baxter, et al.
Journal of Global Antimicrobial Resistance|April 8, 2023
Real-life experience with IV fosfomycin in Canada: Results from the Canadian LEadership on Antimicrobial Real-life usage (CLEAR) registryGeorge Zhanel, Melanie Baxter, Maggie Wong, et al.
Drugs|August 30, 2024
Cefepime-Taniborbactam: A Novel Cephalosporin/β-Lactamase Inhibitor CombinationGeorge G Zhanel, Celine Mansour, Stacey Mikolayanko, et al.
The Journal of Antimicrobial Chemotherapy|April 17, 2013
Trends in antibiotic resistance over time among pathogens from Canadian hospitals: results of the CANWARD study 2007-11Philippe R S Lagacé-Wiens, Heather J Adam, Donald E Low, et al.
Drugs|May 12, 2018
Correction to: Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor CombinationsGeorge G Zhanel, Courtney K Lawrence, Heather Adam, et al.
Antimicrobial Agents and Chemotherapy|September 1, 2010
Prevalence of antimicrobial-resistant pathogens in Canadian hospitals: results of the Canadian Ward Surveillance Study (CANWARD 2008)George G Zhanel, Melanie DeCorby, Heather Adam, et al.
Drugs|December 13, 2017
Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor CombinationsGeorge G Zhanel, Courtney K Lawrence, Heather Adam, et al.
The Journal of Antimicrobial Chemotherapy|September 11, 2019
Trends in antimicrobial resistance over 10 years among key bacterial pathogens from Canadian hospitals: results of the CANWARD study 2007-16Philippe R S Lagacé-Wiens, Heather J Adam, Susan Poutanen, et al.
Drugs|February 13, 2015
Tedizolid: a novel oxazolidinone with potent activity against multidrug-resistant gram-positive pathogensGeorge G Zhanel, Riley Love, Heather Adam, et al.
Pageof 11

Showing results (91-100 of 108) with videos related to

Sort By:
Pageof 11
Drugs|December 20, 2013
Ceftolozane/tazobactam: a novel cephalosporin/β-lactamase inhibitor combination with activity against multidrug-resistant gram-negative bacilliGeorge G Zhanel, Phillip Chung, Heather Adam, et al.
Journal of Global Antimicrobial Resistance|May 13, 2021
Real-life experience with ceftolozane/tazobactam in Canada: results from the CLEAR (Canadian LEadership on Antimicrobial Real-life usage) registryGeorge G Zhanel, Rita Dhami, Melanie Baxter, et al.
Journal of Global Antimicrobial Resistance|April 8, 2023
Real-life experience with IV fosfomycin in Canada: Results from the Canadian LEadership on Antimicrobial Real-life usage (CLEAR) registryGeorge Zhanel, Melanie Baxter, Maggie Wong, et al.
Drugs|August 30, 2024
Cefepime-Taniborbactam: A Novel Cephalosporin/β-Lactamase Inhibitor CombinationGeorge G Zhanel, Celine Mansour, Stacey Mikolayanko, et al.
The Journal of Antimicrobial Chemotherapy|April 17, 2013
Trends in antibiotic resistance over time among pathogens from Canadian hospitals: results of the CANWARD study 2007-11Philippe R S Lagacé-Wiens, Heather J Adam, Donald E Low, et al.
Drugs|May 12, 2018
Correction to: Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor CombinationsGeorge G Zhanel, Courtney K Lawrence, Heather Adam, et al.
Antimicrobial Agents and Chemotherapy|September 1, 2010
Prevalence of antimicrobial-resistant pathogens in Canadian hospitals: results of the Canadian Ward Surveillance Study (CANWARD 2008)George G Zhanel, Melanie DeCorby, Heather Adam, et al.
Drugs|December 13, 2017
Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor CombinationsGeorge G Zhanel, Courtney K Lawrence, Heather Adam, et al.
The Journal of Antimicrobial Chemotherapy|September 11, 2019
Trends in antimicrobial resistance over 10 years among key bacterial pathogens from Canadian hospitals: results of the CANWARD study 2007-16Philippe R S Lagacé-Wiens, Heather J Adam, Susan Poutanen, et al.
Drugs|February 13, 2015
Tedizolid: a novel oxazolidinone with potent activity against multidrug-resistant gram-positive pathogensGeorge G Zhanel, Riley Love, Heather Adam, et al.
Pageof 11